Astrazeneca says Forxiga combination beats use of drug alone

FRANKFURT (Reuters) - AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own.